Amarin Corp Plc (AMRN)

[concapk]

The generics witness did discuss OBVIOUSNESS and how epa/dha had studies ( and drugs) done in the market for over two decades..... BUT AMARINS witness talked how it was NONOBVIOUS to know how the drug VASCEPA would work and what the results would be from the MARINE TRIAL.....

The generics are using AMARIN'S witness presenting NONOVIOUSNESS as their way to invalidate the MARINE PATENTS since the patents were written before the twelve week study was done and results published.... using "WRITTEN DESCRIPTION" as their sole case...

The GENERICS are pinning their whole case on this particular area and its up to AMARIN'S legal team to refute "WRITTEN DESCRIPTION" in their patents...

Their were many legal cases cited to set precedent by the GENERICS.... This case will go to court and maybe appeals court, etc.